Nicholas M. P. King

Center for Drug Evaluation and Research — United States

Medicine · Health Sciences

63h-index13.3kcitations283works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epilepsy research and treatment(34), Pharmacogenetics and Drug Metabolism(34), Pharmaceutical studies and practices(32), Pharmaceutical Practices and Patient Outcomes(27), Analytical Methods in Pharmaceuticals(26)

Publications283 total

predicTox: an integrated database of clinical risk frequencies and human gene expression signatures for cardiotoxic drugs
Database·2026Open Access
predicTox: An integrated database of clinical risk frequencies and human gene expression signatures for cardiotoxic drugs
2025Open Access
Factors in the decline of the African penguin: Are contaminants of emerging concern (CECs) a potential new age stressor?
Marine Pollution Bulletin·2024· 3 cited
Biosecurity on UK Livestock Farms: An Insight Intocurrent Practice
SSRN Electronic Journal·2023Open Access
Contributors
Elsevier eBooks·2021
Medication therapy in older adults
Elsevier eBooks·2021
Vets Cymru: Epidemiology for the busy practitioner
British Small Animal Veterinary Association eBooks·2021
Development of Drug Products for Older Adults
Drug Discovery and Development·2019
IUPHAR International geriatric clinical pharmacology curriculum for medical students
Pharmacological Research·2019· 9 cited
Pharmacotherapy in Older Adults with Cardiovascular Disease: Report from an American College of Cardiology, American Geriatrics Society, and National Institute on Aging Workshop
Journal of the American Geriatrics Society·2018· 79 cited
β2‐adrenoceptor agonists and antagonists and risk of Parkinson's disease
Movement Disorders·2018· 107 cited
Drug Burden Index and Its Association With Hip Fracture Among Older Adults: A National Population-Based Study
The Journals of Gerontology Series A·2018· 33 cited
Issue Information
The Journal of Clinical Pharmacology·2018Open Access
Drug Burden and its Association with Falls Among Older Adults in New Zealand: A National Population Cross-Sectional Study
Drugs & Aging·2017· 29 cited
Improving Therapeutics to Better Care for Older Adults and the Young: Report From the American College of Clinical Pharmacology Workshop
The Journal of Clinical Pharmacology·2017· 3 citedOpen Access
In Vitro–In Vivo Extrapolation of Metabolism- and Transporter-Mediated Drug–Drug Interactions—Overview of Basic Prediction Methods
Journal of Pharmaceutical Sciences·2017· 73 citedOpen Access
Use of Biomedical Ontologies for Integration of Biological Knowledge for Learning and Prediction of Adverse Drug Reactions
Gene Regulation and Systems Biology·2017· 15 citedOpen Access
Issue Information
Clinical Pharmacology in Drug Development·2016Open Access
Linking MedDRA®-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors
Drug Safety·2016· 24 citedOpen Access
Issue Information
The Journal of Clinical Pharmacology·2016Open Access
page 1 of 15Next →

Frequent Co-authors

David J. Greenblatt(23), Richard I. Shader(10), Marcia Divoll(10), Jerold S. Harmatz(3), Barbara Ameer(3), Hermann R. Ochs(3), Nikolai M. Soldatov(3), Ann Locniskar(2), Raul A. Limjuco(2), Janice B. Schwartz(2), Donald E. Mager(2), Sarah N. Hilmer(2), Ping Zhao(2), Naomi Gronich(2), Idit Lavi(2), Gad Rennert(2), Michael J. Hanley(1), Hui C. Kimko(1), James T. Cross(1), Jan Koch‐Weser(1)